(Q34119511)

Revision as of 07:25, 8 December 2021 by KrBot (talk | contribs) (‎Changed English label: Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

author name string

Koki AT

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Leahy KM

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Masferrer JL

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1623-1638

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Regulation of prostaglandin synthase-1 and prostaglandin synthase-2.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Pharmacological analysis of cyclooxygenase-1 in inflammation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Prostaglandins in breast cancer: relationship to disease stage and hormone status

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Aspirin and Related Nonsteroidal Anti-inflammatory Drugs as Chemopreventive Agents Against Colon Cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Nonsteroidal antiinflammatory drugs and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Nonsteroidal antiinflammatory drugs and breast cancer

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

NSAID use and decreased risk of gastrointestinal cancers

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Inhibitory Effect of NS‐398, a Selective Cyclooxygenase‐2 Inhibitor, on Azoxymethane‐induced Aberrant Crypt Foci in Colon Carcinogenesis of F344 Rats

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Inflammatory PGE 2 production is maintained during hypoxia in rheumatoid synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Generation of mutagens during arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Xenobiotic metabolism by prostaglandin H synthase

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-dihydroxy-benzo(a)pyrene to mutagenic derivatives

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Importance of apoptosis in the histopathology of drug related lesions in the large intestine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1623

21 January 2018

Identifiers

10.1517/13543784.8.10.1623

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34119511&oldid=1540297956"